4//SEC Filing
Gao Hanlin 4
Accession 0001684532-25-000005
CIK 0001674930other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 7:10 PM ET
Size
5.4 KB
Accession
0001684532-25-000005
Insider Transaction Report
Form 4
Gao Hanlin
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-08-25$21.50/sh−548$11,783→ 959,091 total
Footnotes (2)
- [F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.
- [F2]The shares were sold in multiple transactions at prices ranging from $21.46 to $21.57, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001684532
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 7:10 PM ET
- Size
- 5.4 KB